EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular prevalence and genotypes of Enterocytozoon bieneusi in cancer patients under chemotherapy in Aegean region of Türkiye

Ayşegül Aksoy Gökmen, Tülay Öncü Öner, Sedef Erkunt Alak, Ecem Su Koçkaya, Mervenur Güvendi, Mehmet Karabey, Ahmet Alacacıoğlu, Bayram Pektaş, Aysu Değirmenci Döşkaya, Muhammet Karakavuk, Mert Döşkaya, Cemal Ün und 3 weitere

BMC Microbiology · 26.06.2024 · 24 (1)

DOI: 10.1186/s12866-024-03369-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Microbiology, online erschienen am 26.06.2024. Verfasst von Ayşegül Aksoy Gökmen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Medical Microbiology, İzmir Katip Çelebi University, İzmir, Türkiye. Hauptthemen laut MEDLINE: Diarrhea, Enterocytozoon, Genotype, Microsporidiosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enterocytozoon bieneusi is the most common species found in humans. Although E. bieneusi has been investigated in humans, genotype profile of E. bieneusi is not known in Türkiye.

Methods

In this study, we screened E. bieneusi in patients ( n = 94) with different types of malignant solid tumors by Real Time PCR and then sequenced E. bieneusi positive samples. All cancer patients were undergoing chemotherapy and had diarrhea. Moreover, as control groups, we also screened E. bieneusi in patients with diarrhea ( n = 50) and without diarrhea ( n = 50).

Results

Among all patients analyzed, 33 (17%) were found to be E. bieneusi -positive. As the patients were categorized, the molecular prevalence of E. bieneusi increased to 25.5% among cancer patients with diarrhea. However, the molecular prevalence of E. bieneusi was found to be lower in patients with presenting only diarrhea (8%) and patients without diarrhea (10%). The high molecular prevalence value detected among cancer patients with diarrhea was also statistically significant compared to other patient groups (P = 0.00112 and P = 0.0269). Among the 33 Real Time PCR positive samples, 10 of them were amplified by nested PCR and among these 10 samples, 6 of them were successfully genotyped. The phylogenetic tree showed the presence of D and Type IV which were also identified in stray cats living in İzmir in our previous study.

Conclusions

High molecular prevalence value indicates the importance of screening stool samples of cancer patients with diarrhea for E. bieneusi and genotyping results indicate that D and Type IV are circulating between humans and cats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiarrheaEnterocytozoonGenotypeMicrosporidiosisNeoplasmsAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultAntineoplastic AgentsDNA, FungalFecesPhylogenyPrevalenceReal-Time Polymerase Chain ReactionSequence Analysis, DNAAnimalsCats

Stichwörter der Autor:innen

E. bieneusiCancer patientsGenotypingReal time PCR

Substanzen

Antineoplastic AgentsDNA, Fungal

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Medical Microbiology, İzmir Katip Çelebi University, İzmir, Türkiye.
  • Faculty of Engineering, Department of Bioengineering, Manisa Celal Bayar University, Manisa, Türkiye.
  • Vaccine Development Application and Research Center, Ege University, İzmir, Türkiye.
  • Faculty of Science, Department of Biology, Molecular Biology Section, Ege University, İzmir, Türkiye.
  • Department of Medical Virology, Basaksehir Çam and Sakura City Hospital, University of Health Science, İstanbul, Türkiye.
  • Faculty of Medicine, Department of Internal Medicine, İzmir Katip Çelebi University, İzmir, Türkiye.

Zitieren

APA

Aksoy Gökmen, A., Öncü Öner, T., Erkunt Alak, S., Koçkaya, E. S., Güvendi, M., Karabey, M., Alacacıoğlu, A., Pektaş, B., Değirmenci Döşkaya, A., Karakavuk, M., Döşkaya, M., Ün, C., Gürüz, A. Y., Kaya, S., & Can, H. (2024). Molecular prevalence and genotypes of Enterocytozoon bieneusi in cancer patients under chemotherapy in Aegean region of Türkiye. BMC Microbiology, 24(1). https://doi.org/10.1186/s12866-024-03369-3

Vancouver

Aksoy Gökmen A, Öncü Öner T, Erkunt Alak S, Koçkaya ES, Güvendi M, Karabey M, et al. Molecular prevalence and genotypes of Enterocytozoon bieneusi in cancer patients under chemotherapy in Aegean region of Türkiye. BMC Microbiology. 2024;24(1). doi:10.1186/s12866-024-03369-3

BibTeX
@article{AksoyGkmen2024,
  author = {Aksoy Gökmen, Ayşegül and Öncü Öner, Tülay and Erkunt Alak, Sedef and Koçkaya, Ecem Su and Güvendi, Mervenur and Karabey, Mehmet and Alacacıoğlu, Ahmet and Pektaş, Bayram and Değirmenci Döşkaya, Aysu and Karakavuk, Muhammet and Döşkaya, Mert and Ün, Cemal and Gürüz, Adnan Yüksel and Kaya, Selçuk and Can, Hüseyin},
  title = {Molecular prevalence and genotypes of Enterocytozoon bieneusi in cancer patients under chemotherapy in Aegean region of Türkiye},
  journal = {BMC Microbiology},
  year = {2024},
  volume = {24},
  number = {1},
  doi = {10.1186/s12866-024-03369-3}
}
Kostenlos starten →